Your browser doesn't support javascript.
loading
Remineralization Rate of Lytic Lesions of the Spine in Multiple Myeloma Patients Undergoing Radiation Therapy.
Zijlstra, Hester; Te Velde, Jens P; Striano, Brendan M; Groot, Olivier Q; de Groot, Tom M; Raje, Noopur; Patel, Chirayu; Husseini, Jad; Delawi, Diyar; Kempen, Diederik H R; Verlaan, Jorrit-Jan; Schwab, Joseph H.
Affiliation
  • Zijlstra H; Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Te Velde JP; Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Striano BM; Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Groot OQ; Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • de Groot TM; Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Raje N; Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Patel C; Department of Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Husseini J; Department of Hematology/Oncology, Center for Multiple Myeloma, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Delawi D; Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Kempen DHR; Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Verlaan JJ; Department of Orthopedic Surgery, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands.
  • Schwab JH; Department of Orthopedic Surgery, OLVG, Amsterdam, The Netherlands.
Global Spine J ; : 21925682241260651, 2024 Jun 10.
Article in En | MEDLINE | ID: mdl-38856741
ABSTRACT
STUDY

DESIGN:

Retrospective cohort study.

OBJECTIVE:

In general, Multiple Myeloma (MM) patients are treated with systemic therapy including chemotherapy. Radiation therapy can have an important supportive role in the palliative management of MM-related osteolytic lesions. Our study aims to investigate the degree of radiation-induced remineralization in MM patients to gain a better understanding of its potential impact on bone mineral density and, consequently, fracture prevention. Our primary outcome measure was percent change in bone mineral density measured in Hounsfield Units (Δ% HU) between pre- and post-radiation measurements, compared to non-targeted vertebrae.

METHODS:

We included 119 patients with MM who underwent radiotherapy of the spine between January 2010 and June 2021 and who had a CT scan of the spine at baseline and between 3-24 months after radiation. A linear mixed effect model tested any differences in remineralization rate per month (ßdifference) between targeted and non-targeted vertebrae.

RESULTS:

Analyses of CT scans yielded 565 unique vertebrae (366 targeted and 199 non-targeted vertebrae). In both targeted and non-targeted vertebrae, there was an increase in bone density per month (ßoverall = .04; P = .002) with the largest effect being between 9-18 months post-radiation. Radiation did not cause a greater increase in bone density per month compared to non-targeted vertebrae (ßdifference = .67; P = .118).

CONCLUSION:

Our results demonstrate that following radiation, bone density increased over time for both targeted and non-targeted vertebrae. However, no conclusive evidence was found that targeted vertebrae have a higher remineralization rate than non-targeted vertebrae in patients with MM.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Global Spine J Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Global Spine J Year: 2024 Document type: Article Affiliation country: Country of publication: